126 related articles for article (PubMed ID: 38447417)
1. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
[TBL] [Abstract][Full Text] [Related]
2. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
3. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease.
Yang X; Chen Z; Luo Z; Yang D; Hao Y; Hu J; Feng J; Zhu Z; Luo Q; Zhang Z; Liang W; Ding G
Cell Signal; 2023 Sep; 109():110777. PubMed ID: 37329999
[TBL] [Abstract][Full Text] [Related]
4. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
Gao Y; Ma Y; Xie D; Jiang H
Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
[TBL] [Abstract][Full Text] [Related]
5. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
6. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
7. Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
Zhu W; Li YY; Zeng HX; Liu XQ; Sun YT; Jiang L; Xia LL; Wu YG
Int Immunopharmacol; 2021 Dec; 101(Pt B):108236. PubMed ID: 34653727
[TBL] [Abstract][Full Text] [Related]
8. Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation.
Zhang ZW; Tang MQ; Liu W; Song Y; Gao MJ; Ni P; Zhang DD; Mo QG; Zhao BQ
Int Immunopharmacol; 2024 Apr; 131():111785. PubMed ID: 38479158
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
[TBL] [Abstract][Full Text] [Related]
10. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
Sun L; Ding M; Chen F; Zhu D; Xie X
PeerJ; 2023; 11():e14826. PubMed ID: 36815984
[TBL] [Abstract][Full Text] [Related]
11. GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.
Li X; Jiang X; Jiang M; Wang ZF; Zhao T; Cao SM; Li QM
Acta Diabetol; 2024 Feb; 61(2):225-234. PubMed ID: 37847379
[TBL] [Abstract][Full Text] [Related]
12. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
[TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
Wang X; Jiang L; Liu XQ; Huang YB; Wang AL; Zeng HX; Gao L; Zhu QJ; Xia LL; Wu YG
Phytomedicine; 2022 Nov; 106():154400. PubMed ID: 36049428
[TBL] [Abstract][Full Text] [Related]
14. Poricoic acid A induces mitophagy to ameliorate podocyte injury in diabetic kidney disease via downregulating FUNDC1.
Wu Y; Deng H; Sun J; Tang J; Li X; Xu Y
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23503. PubMed ID: 37706594
[TBL] [Abstract][Full Text] [Related]
15. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
[TBL] [Abstract][Full Text] [Related]
17. Total Flavones of
Liu BH; Tu Y; Ni GX; Yan J; Yue L; Li ZL; Wu JJ; Cao YT; Wan ZY; Sun W; Wan YG
Front Pharmacol; 2021; 12():667644. PubMed ID: 34335245
[No Abstract] [Full Text] [Related]
18. Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway.
An X; Zhang Y; Cao Y; Chen J; Qin H; Yang L
Nutrients; 2020 May; 12(5):. PubMed ID: 32456088
[TBL] [Abstract][Full Text] [Related]
19. Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
Tan HB; Zhao Q; Chen L
Int Immunopharmacol; 2022 Jun; 107():108680. PubMed ID: 35303505
[TBL] [Abstract][Full Text] [Related]
20. Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axis.
Zhang Z; Ni P; Tang M; Song Y; Liu C; Zhao B
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
